Sept 7 (Reuters) – Neurizon Therapeutics Ltd: * NEURIZON APPOINTS CHIEF EXECUTIVE OFFICER * APPOINTS CHRIS BREMER AS CEO EFFECTIVE 1 OCTOBER 2026 Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Foxconn says third quarter to outperform market expectations on AI strength
TAIPEI, Sept 5 (Reuters) - Foxconn's third-quarter performance is expected to outperform market expectations given…
Foxconn says third quarter to outperform market expectations on AI strength
TAIPEI, Sept 5 (Reuters) - Foxconn's third-quarter performance is expected to outperform market expectations given…
Alcaraz outguns Paul as Sabalenka beats tricky Townsend
VIDEO SHOWS: HIGHLIGHTS FROM DAY EIGHT MATCHES OF THE U.S. OPEN SHOWS: NEW YORK CITY,…
